A Native Whole Blood Thrombin Generation Assay Allows Discrimination of Whole Blood Samples with FVIII Levels below 1%

Christina K. Baumgartner(AbbVie (United States)), Robert R. Montgomery(Versiti Blood Center of Wisconsin), Qizhen Shi(Children's Hospital of Wisconsin), Sandra L. Haberichter(Medical College of Wisconsin), Jonathan Roberts(University Hospitals Sussex NHS Foundation Trust), Paula M. Jacobi(Medical College of Wisconsin)
Blood
December 6, 2014
10.1182/blood.v124.21.4215.4215
Cited by 0

Related Papers

Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
|Journal of Pain|2016|3.1k
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
|Journal of Clinical Investigation|2006|188
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
|Nature|2023|170
Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.
|Journal of Clinical Investigation|1988|164
von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
|Journal of Clinical Investigation|1978|119